255 related articles for article (PubMed ID: 31238579)
1. Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer.
Stojnev S; Krstić M; Čukuranović Kokoris J; Conić I; Petković I; Ilić S; Milosević-Stevanović J; Veličković LJ
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31238579
[No Abstract] [Full Text] [Related]
2. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between Expression of TGF-β1, Smad2, Smad4 and Prognosis
of Patients with Resected Non-small Cell Lung Cancer].
Xie M; He C; Wei S
Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):543-8. PubMed ID: 26383977
[TBL] [Abstract][Full Text] [Related]
4. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study.
Karathanasi V; Tosios KI; Nikitakis NG; Piperi E; Koutlas I; Trimis G; Sklavounou A
J Oral Pathol Med; 2013 May; 42(5):415-23. PubMed ID: 23157422
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of TGF-β signaling pathway in breast cancer patients.
de Kruijf EM; Dekker TJA; Hawinkels LJAC; Putter H; Smit VTHBM; Kroep JR; Kuppen PJK; van de Velde CJH; Ten Dijke P; Tollenaar RAEM; Mesker WE
Ann Oncol; 2013 Feb; 24(2):384-390. PubMed ID: 23022998
[TBL] [Abstract][Full Text] [Related]
10. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
[TBL] [Abstract][Full Text] [Related]
11. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.
Qi Y; Wang CC; He YL; Zou H; Liu CX; Pang LJ; Hu JM; Jiang JF; Zhang WJ; Li F
Int J Clin Exp Pathol; 2013; 6(12):2787-99. PubMed ID: 24294365
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
[TBL] [Abstract][Full Text] [Related]
13. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
14. [Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].
Hua YP; Li SQ; Lai JM; Liang LJ; Peng BG; Liang HZ; Huang JF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1848-52. PubMed ID: 18971187
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus.
Pühringer-Oppermann F; Sarbia M; Ott N; Brücher BL
Int J Colorectal Dis; 2010 Apr; 25(4):515-21. PubMed ID: 20012971
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
17. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
[TBL] [Abstract][Full Text] [Related]
18. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
19. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
20. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
